IRIS
POLLICINO, Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.506
NA - Nord America 6.349
AS - Asia 3.196
SA - Sud America 1.033
Continente sconosciuto - Info sul continente non disponibili 224
AF - Africa 93
OC - Oceania 13
Totale 17.414
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.209
RU - Federazione Russa 3.214
SG - Singapore 1.241
CN - Cina 999
BR - Brasile 912
IE - Irlanda 779
SE - Svezia 706
IT - Italia 471
HK - Hong Kong 376
DE - Germania 303
FR - Francia 204
FI - Finlandia 186
PL - Polonia 181
UA - Ucraina 180
VN - Vietnam 170
GB - Regno Unito 115
IN - India 93
CA - Canada 60
BD - Bangladesh 54
MX - Messico 43
IQ - Iraq 37
TR - Turchia 37
AR - Argentina 33
BE - Belgio 33
ZA - Sudafrica 29
ID - Indonesia 28
ES - Italia 25
NL - Olanda 23
CO - Colombia 22
JP - Giappone 22
PK - Pakistan 21
CZ - Repubblica Ceca 20
AT - Austria 19
EC - Ecuador 18
MA - Marocco 18
UZ - Uzbekistan 18
AE - Emirati Arabi Uniti 13
KE - Kenya 11
PY - Paraguay 11
VE - Venezuela 11
HN - Honduras 8
JM - Giamaica 8
JO - Giordania 8
LT - Lituania 8
NP - Nepal 8
NZ - Nuova Zelanda 8
PE - Perù 8
SA - Arabia Saudita 8
TN - Tunisia 8
CL - Cile 7
GR - Grecia 7
AZ - Azerbaigian 6
BO - Bolivia 6
CI - Costa d'Avorio 6
KG - Kirghizistan 6
LB - Libano 6
MY - Malesia 6
PH - Filippine 6
AL - Albania 5
AU - Australia 5
BG - Bulgaria 5
EG - Egitto 5
UY - Uruguay 5
CH - Svizzera 4
CR - Costa Rica 4
GT - Guatemala 4
IR - Iran 4
OM - Oman 4
SV - El Salvador 4
AO - Angola 3
DZ - Algeria 3
IL - Israele 3
KZ - Kazakistan 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SN - Senegal 3
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
KR - Corea 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
PT - Portogallo 2
QA - Qatar 2
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
KW - Kuwait 1
LU - Lussemburgo 1
Totale 17.181
Salva come PNG Salva come JPEG
Città #
Ashburn 1.408
Moscow 975
Dublin 779
Dallas 729
Singapore 722
Chandler 543
Nyköping 408
Hong Kong 376
Jacksonville 372
Beijing 359
San Jose 311
Messina 259
Council Bluffs 219
Warsaw 167
Los Angeles 147
The Dalles 142
Princeton 119
Ann Arbor 117
Munich 106
Lauterbourg 102
Medford 98
Cambridge 90
Des Moines 85
São Paulo 77
New York 70
Ho Chi Minh City 67
Boardman 63
Dearborn 51
Houston 50
Helsinki 47
Buffalo 43
Santa Clara 43
Jinan 41
Turku 40
Frankfurt am Main 37
Wilmington 36
Woodbridge 36
Brussels 32
Orem 32
Tianjin 32
Brasília 31
Hanoi 31
Belo Horizonte 29
Guangzhou 29
Pune 28
Redondo Beach 27
San Mateo 27
Phoenix 25
Shanghai 23
Chennai 22
Rio de Janeiro 22
Falls Church 21
Nanjing 21
Tokyo 21
Brooklyn 20
Atlanta 19
Shenzhen 19
Boston 18
Rome 18
Stockholm 18
Zhengzhou 18
Chicago 17
Columbus 17
Jakarta 17
Mexico City 17
Nuremberg 17
Tashkent 17
Dong Ket 16
Johannesburg 16
Montreal 15
Shenyang 15
London 14
Porto Alegre 14
Rosolini 14
Baghdad 13
Brno 13
Hebei 13
San Francisco 13
Amsterdam 12
Denver 12
Dhaka 12
Lahore 12
Lappeenranta 12
Seattle 12
Haiphong 11
Manchester 11
Norwalk 11
Salvador 11
Düsseldorf 10
Guarulhos 10
Mumbai 10
North Bergen 10
Poplar 10
Catania 9
Fortaleza 9
Haikou 9
Hangzhou 9
Nairobi 9
Toronto 9
Changsha 8
Totale 10.403
Salva come PNG Salva come JPEG
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 386
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 300
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 266
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 264
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 244
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 230
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 226
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 219
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 217
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 215
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 210
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 205
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 200
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 197
Control of cccDNA function in hepatitis B virus infection. 196
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 195
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 193
Cirrhosis related to wild-type HBV infection in siblings with A3 - B35 - Cw4 HLA class I phenotype. 185
[A glance into the past ... Southern and northern blot: really superseded?] 182
Mitochondrial DNA is a target of HBV integration 182
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 180
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 179
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 177
A 2010 update on occult hepatitis B infection. 177
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 177
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice 176
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 176
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 173
Clinical virology of hepatitis B virus infection 172
Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021 171
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 169
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 168
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 168
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 168
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 166
Conserved transactivating and pro-apoptotic functions of hepadnaviral X protein in ortho- and avihepadnaviruses. 163
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 162
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 161
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 160
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 159
Disease progression and liver cancer in the ferroportin disease. 157
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 156
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 156
Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. 155
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 154
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 154
Obesity and liver cancer 154
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook 153
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 151
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 151
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 149
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 148
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 148
NS3 genetic variability in hepatitis C virus genotype-1b isolates from liver specimens and blood samples of treatment naïve patients with chronic hepatitis C 147
Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients 145
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 145
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 N(IL-8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INERFERON ALFA ANTIVIRAL ACITIVITY 143
Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study 141
Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 141
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 PRODUCTION WHICH IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY IN HEPATOMA CELL LINES 136
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C. 136
Assessing immunological and virological responses in the liver: implications for the cure of chronic hepatitis B virus infection 135
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 134
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications. 133
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo 131
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 131
FULMINANT-HEPATITIS ASSOCIATED WITH THE INTRAFAMILIAR SPREAD OF A PRE-S2 DEFECTIVE HBV VARIANT AND THE LATE EMERGENCE OF HBEAG- MINUS VIRAL STRAINS 130
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. 130
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 130
PRE-S GENETIC VARIANTS ARE HIGHLY PREVALENT AND SIGNIFICANTLY CORRELATE WITH LOWER LEVELS OF HBSAG IN ACTIVE HBV INFECTIONS 128
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 126
Targeting Hepatitis B virus infected cells with a T-cell receptor like antibody 125
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. 120
Statements from the Taormina expert meeting on occult hepatitis B virus infection. 119
Severe outcome of hepatitis B virus (HBV) infection and lack of HBV e antigen-defective virus emergence in patients homozygous for HLA class I alleles. 118
Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease 117
Occult HBV infection 117
Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases 117
Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR. 116
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 115
Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. 115
NS3 Q80K Polymorphism in viral isolates from Liver Tissues and serum samples of naive HCV genotype 1a Patients 115
Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure 114
Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance 114
Occult hepatitis B virus infection 113
HBV-integration studies in the clinic: Role in the natural history of infection 112
Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. 110
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3 infected patients within the Italian network VIRONET-C 109
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 108
Occult hepatitis B virus infection: an update 106
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease 105
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 103
Hepatitis Delta Virus and Hepatocellular Carcinoma 102
Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma 102
Pro-apoptotic effect of the hepatitis B virus X gene. 97
p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. 96
The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. 95
Hepatitis B viral replication influences the expression of natural killer cell ligands 94
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. 93
Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways. 93
Totale 15.502
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022738 0 57 27 30 57 16 63 33 18 99 99 239
2022/20232.196 164 250 104 176 138 224 45 100 906 14 61 14
2023/2024719 50 111 26 61 41 103 2 228 3 23 20 51
2024/20252.658 47 19 80 227 115 121 137 519 554 150 228 461
2025/20268.402 360 649 611 546 700 1.592 1.013 1.020 1.103 399 181 228
2026/2027498 225 273 0 0 0 0 0 0 0 0 0 0
Totale 17.414